CATALOGO DEI PRODOTTI DELLA RICERCA

CRIPPA, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.298
EU - Europa 3.880
AS - Asia 2.695
SA - Sud America 396
AF - Africa 75
Continente sconosciuto - Info sul continente non disponibili 66
OC - Oceania 9
Totale 11.419
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.199
RU - Federazione Russa 1.450
GB - Regno Unito 1.094
SG - Singapore 1.076
CN - Cina 782
BR - Brasile 330
IT - Italia 248
VN - Vietnam 247
DE - Germania 232
HK - Hong Kong 231
SE - Svezia 187
FI - Finlandia 173
IE - Irlanda 164
FR - Francia 155
KR - Corea 82
BD - Bangladesh 77
CA - Canada 58
UA - Ucraina 44
NL - Olanda 35
IN - India 30
TR - Turchia 30
AR - Argentina 29
JP - Giappone 27
NG - Nigeria 26
MX - Messico 24
ID - Indonesia 21
BE - Belgio 19
IQ - Iraq 16
PL - Polonia 16
ZA - Sudafrica 13
AT - Austria 12
PK - Pakistan 11
EC - Ecuador 10
SA - Arabia Saudita 10
LT - Lituania 9
AE - Emirati Arabi Uniti 8
AU - Australia 8
CZ - Repubblica Ceca 8
ES - Italia 8
PH - Filippine 8
TG - Togo 8
CL - Cile 7
IR - Iran 7
MA - Marocco 7
RO - Romania 7
BJ - Benin 5
CO - Colombia 5
IL - Israele 5
PY - Paraguay 5
UZ - Uzbekistan 5
AL - Albania 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
JM - Giamaica 4
CR - Costa Rica 3
EU - Europa 3
JO - Giordania 3
LB - Libano 3
OM - Oman 3
UY - Uruguay 3
VE - Venezuela 3
BG - Bulgaria 2
EG - Egitto 2
HU - Ungheria 2
KE - Kenya 2
KH - Cambogia 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
RE - Reunion 2
RS - Serbia 2
SV - El Salvador 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DJ - Gibuti 1
GA - Gabon 1
GF - Guiana Francese 1
HN - Honduras 1
IS - Islanda 1
KN - Saint Kitts e Nevis 1
KZ - Kazakistan 1
LC - Santa Lucia 1
ME - Montenegro 1
MN - Mongolia 1
NC - Nuova Caledonia 1
NI - Nicaragua 1
NO - Norvegia 1
QA - Qatar 1
SC - Seychelles 1
SI - Slovenia 1
SO - Somalia 1
SX - ???statistics.table.value.countryCode.SX??? 1
TH - Thailandia 1
Totale 11.358
Salva come PNG Salva come JPEG
Città #
Southend 956
Singapore 603
Moscow 522
Ashburn 427
San Jose 424
Jacksonville 416
Chandler 393
Dallas 313
Woodbridge 292
Ann Arbor 233
Hong Kong 231
Dublin 164
Council Bluffs 155
Houston 154
Beijing 114
Verona 112
The Dalles 107
Ho Chi Minh City 82
Wilmington 75
Munich 65
Lawrence 64
New York 64
Princeton 64
Los Angeles 61
Hanoi 57
Jinan 55
Nanjing 47
Shenyang 47
Santa Clara 41
Buffalo 40
Hebei 39
Helsinki 36
Sindelfingen 35
Tianjin 34
São Paulo 31
Columbus 29
Milan 29
Haikou 27
Abuja 26
Orem 25
Tokyo 25
Toronto 24
Lancaster 22
London 22
Redondo Beach 21
Seattle 20
Zhengzhou 20
Brussels 18
Ningbo 18
Turku 18
Da Nang 17
Nanchang 17
Changsha 16
Montreal 16
Frankfurt am Main 15
Taiyuan 15
Belo Horizonte 14
Haiphong 14
Rome 14
San Francisco 14
Taizhou 14
Warsaw 14
Chicago 13
Guangzhou 13
Amsterdam 12
Chennai 12
Hangzhou 12
Jiaxing 12
Rio de Janeiro 12
Brooklyn 11
Stockholm 11
Boardman 10
Denver 10
Falls Church 10
Grafing 10
Lanzhou 10
Manchester 10
Mexico City 10
Seoul 10
Vienna 10
Norwalk 9
Shanghai 9
Atlanta 8
Barnet 8
Boston 8
Jakarta 8
Johannesburg 8
Lappeenranta 8
Lomé 8
Charlotte 7
Poplar 7
Auburn Hills 6
Brasília 6
Düsseldorf 6
Fairfield 6
Hải Dương 6
Jeddah 6
Paris 6
Baghdad 5
Cagliari 5
Totale 7.415
Salva come PNG Salva come JPEG
Nome #
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. 245
Amylase value in drains after pancreatic resection as predictive factor of postoperative pancreatic fistula: results of a prospective study in 137 patients. 242
Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreas 234
UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR AS A NEW USEFUL MARKER IN PANCREATIC CANCER: PRELIMINARY RESULTS 216
Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Results of a prospective protocol on the management of 109 consecutive patients. 212
Acute pancreatitis at the beginning of the 21st century: the state of the art. 207
Ampullary somatostatinomas and jejunal gastrointestinal stromal tumor in a patient with Von Recklinghausen's disease. 201
Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms 196
PTPRG Expression Correlates with Tolerogenic Phenotype in Dendritic Cells Derived from Pancreatic Cancer Patients 192
Anastomotic leakage in pancreatic surgery. 192
Anastomotic leakage in pancreatic surgery. 191
Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. 191
Clinical and biological behavior of pancreatic solid pseudopapillary tumors: report on 31 consecutive patients. 190
Laparoscopic rectal resection for severe endometriosis of the mid and low rectum: technique and operative results. 188
Enucleation of pancreatic neoplasms. 185
Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance 181
SILS cholecystectomy, early experience of a single institution: pilot study of 21 cases. 180
THE VALUE OF (18)FLUOR-DEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY (18FDG-PET/CT) IN RESECTABLE PANCREATIC CANCER: A PROSPECTIVE STUDY 180
Primary tumour resection in metastatic nonfunctioning pancreatic endocrine carcinomas. 180
ASO Visual Abstract: Surgery for IPMN of the Pancreas—Preoperative Factors Tipping the Scale of Decision-Making 176
Anastomotic leakage in pancreatic surgery. 176
Parenchyma-preserving resections for small nonfunctioning pancreatic endocrine tumors. 175
Surveillance for Presumed BD-IPMN of the Pancreas: Stability, Size, and Age Identify Targets for Discontinuation 174
Incidental diagnosis as prognostic factor in different tumor stages of nonfunctioning pancreatic endocrine tumors 174
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey 170
Parenchyma-sparing resections for pancreatic neoplasms. 168
Futility of Up-Front Resection for Anatomically Resectable Pancreatic Cancer 167
Pancreatoblastoma in adults: a review of the literature. 165
Enucleation of pancreatic neoplasms 162
Middle pancreatectomy: indications, short- and long-term operative outcomes. 162
Contrast-Enhanced Ultrasonography of the Pancreas 160
Extent of surgical resections for intraductal papillary mucinous neoplasms. 159
Surgical management of insulinomas: short- and long-term outcomes after enucleations and pancreatic resections. 159
Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma. 157
Early Versus Late Drain Removal After Standard Pancreatic Resections Results of a Prospective Randomized Trial 151
Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. 150
Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes. 149
Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy 149
Implications of the new histological classification (WHO 2010) for pancreatic neuroendocrine neoplasms. 149
Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling 144
Open pancreaticogastrostomy after pancreaticoduodenectomy: a pilot study. 142
The role of laparoscopy in advanced pancreatic cancer diagnosis. 140
Splenic Artery Invasion in Pancreatic Adenocarcinoma of the Body and Tail - a Novel Prognostic Parameter for Patients Selection 140
Results of First-round of Surveillance in Individuals at High-risk of Pancreatic Cancer from the AISP (Italian Association for the Study of the Pancreas) Registry 140
ASO Visual Abstract: Ca 19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 139
Surgical strategy in the treatment of pancreatic neuroendocrine tumors. 139
Verona Evidence-Based Meeting (EBM) 2020 on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: Meeting Report 138
Pleomorphic liposarcoma of the axilla metastatic to the pancreas. 136
Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio 136
Long-term outcomes and prognostic factors in neuroendocrine carcinomas of the pancreas: Morphology matters 135
Pancreatic anastomotic leakage after pancreaticoduodenectomy in 1,507 patients: a report from the Pancreatic Anastomotic Leak Study Group. 134
Mucin-producing neoplasms of the pancreas: an analysis of distinguishing clinical and epidemiologic characteristics. 133
Surgical treatment of pancreatic tumors in childhood and adolescence: uncommon neoplasms with favorable outcome. 133
Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-Making 131
Pancreatic insufficiency after different resections for benign tumours. 131
Cure Probabilities After Resection of Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Analysis of 2554 Patients 129
Surgical strategy in the treatment of pancreatic neuroendocrine tumors. 127
Pancreatic metastasis from leiomyosarcoma of the broad ligament of the uterus. 123
Intraductal papillary mucinous neoplasms of the biliary and pancreatic ducts-A shape shifting outlook into an increasingly recognized disease. 123
Guidelines on Pancreatic Cystic Neoplasms: Major Inconsistencies With Available Evidence and Clinical Practice- Results From an International Survey 118
Improving cytological diagnosis of pancreatic cysts: Is it clinically necessary or just the latest fashion? 114
Pancreatic cystic tumours: when to resect, when to observe 114
Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor 114
Rectal indomethacin to prevent post-ERCP pancreatitis. 110
Surgical strategy in the treatment of pancreatic neuroendocrine tumors 104
Splenic Artery Invasion in Pancreatic Adenocarcinoma of the Body and Tail: A Novel Prognostic Parameter for Patient Selection 104
Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors 102
Peptide receptor radionuclide therapy as neoadjuvant therapy for resectable or potentially resectable pancreatic neuroendocrine neoplasms 99
ASO Author Reflections: Recurrence Following Post-neoadjuvant Pancreatectomy: How Can We Do Better? 98
Real-world costs and dynamics of surveillance in patients who underwent surgery for low-risk branch duct intraductal papillary mucinous neoplasms 94
Laparoscopic ileocecal resection for bowel endometriosis. 93
Intraductal papillary mucinous neoplasms (IPMNs): is it time to (sometimes) spare the knife? 89
Identification of patients with branch-duct intraductal papillary mucinous neoplasm and very low risk of cancer: multicentre study 85
Intraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms 85
The size of well differentiated pancreatic neuroendocrine tumors correlates with Ki67 proliferative index and is not associated with age 85
Regret affects the choice between neoadjuvant therapy and upfront surgery for potentially resectable pancreatic cancer 63
Totale 11.419
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.578
article - articoli 35.508
book - libri 0
conference - conferenze 1.619
curatela - curatele 0
other - altro 451
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.156
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022425 0 116 4 30 14 20 15 29 21 9 57 110
2022/20231.051 80 121 103 151 89 244 27 92 108 6 24 6
2023/2024534 19 59 53 70 57 81 23 31 9 27 77 28
2024/20251.613 82 87 40 274 97 63 126 72 218 93 167 294
2025/20264.797 339 264 312 756 1.191 315 518 217 381 239 126 139
2026/2027134 45 89 0 0 0 0 0 0 0 0 0 0
Totale 11.419